04:46 PM EDT, 03/27/2025 (MT Newswires) -- Crinetics Pharmaceuticals ( CRNX ) said Thursday that the European Medicines Agency has validated its marketing authorization application for paltusotine, an oral treatment for endocrine disorder acromegaly. The marketing authorization application will now undergo review by the Committee for Medicinal Products for Human Use. This submission is supported by 18 clinical trials, including...

WASHINGTON (Reuters) -The Trump administration's nominee to oversee a $42 billion government fund to bring high-speed broadband internet to unserved or underserved parts of the United States denied on Thursday that she would administer the program to benefit Starlink owner Elon Musk. Democrats have suggested that Musk, a billionaire and close adviser to President Donald Trump, could receive as much...

04:45 PM EDT, 03/27/2025 (MT Newswires) -- Michael Scarpelli, Chief Financial Officer, on March 25, 2025, sold 300,000 shares in Snowflake (SNOW) for $48,964,020. Following the Form 4 filing with the SEC, Scarpelli has control over a total of 1,086,098 Class A common shares of the company, with 292,610 shares held directly and 793,488 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1640147/000164014725000061/xslF345X05/wk-form4_1743107399.xml ...

04:45 PM EDT, 03/27/2025 (MT Newswires) -- David Fisher, Director, Chief Executive Officer, on March 25, 2025, sold 5,000 shares in Enova International ( ENVA ) for $508,769. Following the Form 4 filing with the SEC, Fisher has control over a total of 348,223 common shares of the company, with 348,223 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1529864/000095017025046130/xslF345X05/ownership.xml ...